Don’t Miss: Vale S.A. (NYSE:VALE), Oncothyreon Inc (NASDAQ:ONTY), Itron (NASDAQ:ITRI), Agenus Inc. (NASDAQ:AGEN), Forbes Energy Services (NASDAQ:FES)

Vale S.A. (NYSE:VALE) in last trading activity fell -6.18% to close at $6.68. Company weekly performance is -12.79% while its quarterly performance stands at -13.66%. Vale S.A. (NYSE:VALE) is -53.21% away from its 52 week high. Macquarie has downgraded shares of Vale SA from an outperform rating to a neutral rating.

Oncothyreon Inc (NASDAQ:ONTY) in last trading activity advanced 6.58% to close at $2.59. Company weekly performance is 69.28% while its quarterly performance stands at 67.10%. Oncothyreon Inc (NASDAQ:ONTY) is -28.06% away from its 52 week high. Oncothyreon Inc (NASDAQ:ONTY) on May 11, 2015, released financial results for the first quarter ended March 31, 2015. Net loss for the three months ended March 31, 2015 was $7.9 million, or $0.08 per basic and diluted share, compared with a net loss of $9.6 million, or $0.14 per basic and diluted share, for the comparable period in 2014.

On last trading day Itron, Inc. (NASDAQ:ITRI) advanced 0.77% to close at $36.69. Its volatility for the week is 2.02% while volatility for the month is 2.69%. ITRI’s sales growth for past 5 years was 3.20% and its EPS growth for past 5 years was -57.40%. Itron, Inc. (NASDAQ:ITRI) monthly performance is 0.52%. On 13 May, Itron, Inc. (NASDAQ:ITRI) has launched the Itron Riva Developers Community, encouraging engineers, developers and manufacturers to participate in creating applications for its Itron Riva platform.

Agenus Inc. (NASDAQ:AGEN) in last trading activity moved down -1.45% to close at $6.80. Company weekly performance is 1.04% while its quarterly performance stands at 31.78%. Agenus Inc. (NASDAQ:AGEN) is -15.00% away from its 52 week high. On 15 May, Agenus Inc. (NASDAQ:AGEN) announced data on continuing survival from a phase II study on its cancer vaccine candidate, prophage, which is being developed for the treatment of glioblastoma multiforme (GBM). The data from the study will be presented orally at the annual meeting of the American Society of Clinical Oncology.

On last trading day Forbes Energy Services Ltd. (NASDAQ:FES) advanced 1.95% to close at $1.57. Its volatility for the week is 23.61% while volatility for the month is 13.44%. FES’s sales growth for past 5 years was 18.80% and its EPS growth for past 5 years was 25.20%. Forbes Energy Services Ltd. (NASDAQ:FES) monthly performance is 17.17%. On 14 May, Forbes Energy Services Ltd. (NASDAQ:FES) announced financial and operating results for the three months ended March 31, 2015. Consolidated revenues were $84.3 million for the first quarter of 2015, compared to $111.7 million for the fourth quarter of 2014. Gross profit decreased to $23.8 million, or 28.2% of revenues, in the first quarter of 2015, compared to $25.9 million, or 23.2% of revenues, in the fourth quarter of 2014. GAAP net loss attributable to common shares was $4.6 million, or $0.21 per diluted share, for the first quarter of 2015, compared to net loss attributable to common shares of $4.2 million, or $0.19 per diluted share for the fourth quarter of 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *

*